IDIBELL Participates in the Creation of a Bioinformatics Platform to Promote Education
News Feb 18, 2013
IDIBELL, along with nine other research institutions in the field of biomedicine, three Catalan universities, the Barcelona Supercomputing Center-Centro National de Supercomputación (BSC-CNS) and BioCat signed on February 14th an agreement for the creation of the Bioinformatics Barcelona (BiB), a platform which aims is to turn the Barcelona area as global reference center in bioinformatics, through cooperation between universities, research centers, and other public and private entities.
Bioinformatics is an area of research in applied computer science and information technology used for the treatment of biological data. BiB promoters consider this area as strategic science that makes sense of the vast amounts of biological data generated. So BiB proposes to boost this area of specialization that is necessary in all areas of life sciences and has a profound impact on fields as diverse as human health, the food industry, the environment and biotechnology.
Promoting high-level postgraduate studies
It seeks to take advantage of the critical mass of internationally renowned researchers in bioinformatics in the Barcelona area to promote high-level postgraduate studies, including the training of new professionals, and to develop scientific and transfer knowledge initiatives.
The agreement is a commitment between the different institutions to develop, within six months, the strategic plan to formally constitute the initiative. The task of preparing this plan will be led by Anna Ripoll, Professor of Architecture and Computer Technology and rector at the Autonomous University of Barcelona (UAB), who will be its executive chairman. Ferran Sanz, head of Biomedical Informatics at the UPF, will be its scientific director.
MIT researchers have developed a cryptographic system that could help neural networks identify promising drug candidates in massive pharmacological datasets, while keeping the data private. Secure computation done at such a massive scale could enable broad pooling of sensitive pharmacological data for predictive drug discovery.
The architecture of each person’s brain is unique, and differences may influence how quickly people can complete various cognitive tasks.o learn more, scientists are developing a new tool — computational models of the brain — to simulate how the structure of the brain may impact brain activity and, ultimately, human behavior.READ MORE
2nd International Conference on Computational Biology and Bioinformatics
May 17 - May 18, 2019